Evidence map›Paper›PMID 27620011›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2016

Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease.

Deborah L Harrington, Jeffrey D Long, Sally Durgerian, Lyla Mourany, Katherine Koenig, Aaron Bonner-Jackson, Jane S Paulsen, PREDICT-HD Investigators of the Huntington Study Group, Stephen M Rao

Open access · greenAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Diffusion imaging in Huntington's disease: comprehensive review.Journal of neurology, neurosurgery, and psychiatry · 2020
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Deborah L HarringtonDepartment of Radiology, University of California, San Diego, La Jolla, California, USA.
Jeffrey D LongCarver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
Sally DurgerianDepartment of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Lyla MouranySchey Center for Cognitive Neuroimaging, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Katherine KoenigImaging Sciences, Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Aaron Bonner-JacksonLou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Ohio, USA.
Jane S PaulsenCarver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
PREDICT-HD Investigators of the Huntington Study Group
Stephen M RaoSchey Center for Cognitive Neuroimaging, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Cleveland Clinic · USUniversity of Iowa · USCognitive Neuroimaging Lab · FRLou Ruvo Brain Institute · USMedical College of Wisconsin · USThe Neurological Institute · USVA San Diego Healthcare System · US

Funding

NEUROBIOLOGICAL PREDICTORS OF HUNTINGTON'S DISEASER01NS040068 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S · 2001 to 2013
$48.5M
Cognitive and functional brain changes in preclinical Huntington's disease (HD)R01NS054893 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S · 2007 to 2011
$2.0M
Functional Connectivity in Premanifest Huntington's DiseaseU01NS082083 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI RAO, STEPHEN MARK · 2012 to 2014
$1.2M
Cognition in Parkinson's DiseaseI01CX000146 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI HARRINGTON, DEBORAH LYNN · 2009 to 2021
–
CSRD VA I01 CX000146NINDS NIH HHS R01 NS040068NINDS NIH HHS R01 NS054893NINDS NIH HHS U01 NS082083
6 · The paper itself

Abstract

objectivesDiffusivity in white-matter tracts is abnormal throughout the brain in cross-sectional studies of prodromal Huntington's disease. To date, longitudinal changes have not been observed. The present study investigated cross-sectional and longitudinal changes in white-matter diffusivity in relationship to the phase of prodromal Huntington's progression, and compared them with changes in brain volumes and clinical variables that track disease progression.

methodsDiffusion MRI profiles were studied for 2 years in 37 gene-negative controls and 64 prodromal Huntington's disease participants in varied phases of disease progression. To estimate the relative importance of diffusivity metrics in the prodromal phase, group effects were rank ordered relative to those obtained from analyses of brain volumes, motor, cognitive, and sensory variables.

resultsFirst, at baseline diffusivity was abnormal throughout all tracts, especially as individuals approached a manifest Huntington's disease diagnosis. Baseline diffusivity metrics in 6 tracts and basal ganglia volumes best distinguished among the groups. Second, group differences in longitudinal change in diffusivity were localized to the superior fronto-occipital fasciculus, most prominently in individuals closer to a diagnosis. Group differences were also observed in longitudinal changes of most brain volumes, but not clinical variables. Last, increases in motor symptoms across time were associated with greater changes in the superior fronto-occipital fasciculus diffusivity and corpus callosum, cerebrospinal fluid, and lateral ventricle volumes.

conclusionsThese novel findings provide new insights into changes within 2 years in different facets of brain structure and their clinical relevance to changes in symptomatology that is decisive for a manifest Huntington's diagnosis. © 2016 International Parkinson and Movement Disorder Society.

Indexed as

Disease ProgressionProdromal SymptomsAdultBasal GangliaCross-Sectional StudiesDiffusion Magnetic Resonance ImagingDiffusion Tensor ImagingFemaleHumansHuntington DiseaseLongitudinal StudiesMaleMiddle AgedWhite Matterbrain volumecognitiondiffusion tensor imagingHuntington's diseasemotor symptoms

Identifiers

PMID27620011
PMCPMC5115975
OpenAlexW2522532977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.